NVZMY Financials: Novozymes A/S AI Analysis



Financials

NVZMY Financial

Novozymes A/S

$59.04

5.04%

$2.83

At close: Jun 09, 16:00:00 GMT-4

-100%

$-59.04

Post-market: Jun 09, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$56.2

Open

$56.81

Day's Range

52 week range

Volume

20.3K

Avg.Volume

89.7K

Dividend yield

EPS (TTM)

1.50

Market Cap

What is NOVONESIS A S?

Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	4,199	1,119	996	1,064	1,018	1,077
Revenue Growth (YoY)	-15%	4%	-50%	--	-44%	--
Cost of Revenue	1,917	484	437	521	474	483
Gross Profit	2,281	634	558	543	544	594
Selling, General & Admin	944	244	249	229	220	212
Research & Development	477	120	128	118	109	107
Operating Expenses	1,401	361	370	344	324	318
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	755	256	152	171	174	244
Income Tax Expense	158	57	29	33	37	58
Net Income	596	199	122	138	136	186
Net Income Growth	21%	7%	-49%	--	115.99%	--
Shares Outstanding (Diluted)	467.2	467.2	467.12	467.4	467.7	468.1
Shares Change (YoY)	0%	0%	1%	--	2%	--
EPS (Diluted)	1.27	0.42	0.26	0.29	0.29	0.39
EPS Growth	20%	7%	-50%	--	109%	--
Free Cash Flow	773	74	101	360	237	51
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	54.32%	56.65%	56.02%	51.03%	53.43%	55.15%
Operating Margin	20.95%	24.39%	18.77%	18.7%	21.51%	25.53%
Profit Margin	14.19%	17.78%	12.24%	12.96%	13.35%	17.27%
Free Cash Flow Margin	18.4%	6.61%	10.14%	33.83%	23.28%	4.73%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	880	273	187	199	219	275
EBIT Margin	20.95%	24.39%	18.77%	18.7%	21.51%	25.53%
Effective Tax Rate	20.92%	22.26%	19.07%	19.29%	21.26%	23.77%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

4,199

1,119

996

1,064

1,018

1,077

Revenue Growth (YoY)

-15%

-50%

-44%

Cost of Revenue

1,917

484

437

521

474

483

Gross Profit

2,281

634

558

543

544

594

Selling, General & Admin

944

244

249

229

220

212

Research & Development

477

120

128

118

109

107

Operating Expenses

1,401

361

370

344

324

318

Other Non Operating Income (Expenses)

Pretax Income

755

256

152

171

174

244

Income Tax Expense

158

Net Income

596

199

122

138

136

186

Net Income Growth

21%

-49%

115.99%

Shares Outstanding (Diluted)

467.2

467.12

467.4

467.7

468.1

Shares Change (YoY)

EPS (Diluted)

1.27

0.42

0.26

0.29

0.39

EPS Growth

20%

-50%

109%

Free Cash Flow

773

101

360

237

Free Cash Flow Per Share

Gross Margin

54.32%

56.65%

56.02%

51.03%

53.43%

55.15%

Operating Margin

20.95%

24.39%

18.77%

18.7%

21.51%

25.53%

Profit Margin

14.19%

17.78%

12.24%

12.96%

13.35%

17.27%

Free Cash Flow Margin

18.4%

6.61%

10.14%

33.83%

23.28%

4.73%

EBITDA

EBITDA Margin

D&A For EBITDA

EBIT

880

273

187

199

219

275

EBIT Margin

20.95%

24.39%

18.77%

18.7%

21.51%

25.53%

Effective Tax Rate

20.92%

22.26%

19.07%

19.29%

21.26%

23.77%

Follow-Up Questions

What are Novozymes A/S's key financial statements?



According to the latest financial statement (Form-10K), Novozymes A/S has a total asset of $0, Net loss of $0

What are the key financial ratios for NVZMY?



Novozymes A/S's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Novozymes A/S's revenue broken down by segment or geography?



Novozymes A/S largest revenue segment is Bioenergy, at a revenue of 596,326,170 in the most earnings release.For geography, Europe, Middle East & Africa is the primary market for Novozymes A/S, at a revenue of 1,440,200,000.

Is Novozymes A/S profitable?



no, according to the latest financial statements, Novozymes A/S has a net loss of $0

Does Novozymes A/S have any liabilities?



no, Novozymes A/S has liability of 0

How many outstanding shares for Novozymes A/S?



Novozymes A/S has a total outstanding shares of 0

Novozymes A/S (NVZMY) Financial

NVZMY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NOVONESIS A S?

Novozymes A/S (NVZMY) Financial

NVZMY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NOVONESIS A S?

NVZMY Income

Follow-Up Questions

What are Novozymes A/S's key financial statements?

What are the key financial ratios for NVZMY?

How is Novozymes A/S's revenue broken down by segment or geography?

Is Novozymes A/S profitable?

Does Novozymes A/S have any liabilities?

How many outstanding shares for Novozymes A/S?